Limited mutagenicity of electronic cigarettes in mouse or human cells in vitro

Lung Cancer

Volumn 112, Issue , 2017, Pages 41-46

  Tommasi, Stella ^a   Bates, Steven E ^b   Behar, Rachel Z ^c   Talbot, Prue ^c   Besaratinia, Ahmad ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cII transgene; Mouse embryonic fibroblasts; Mutation; supF assay; Vaping

Indexed keywords

4 BIPHENYLAMINE; BENZO[A]PYRENE; CARCINOGEN; GENOMIC DNA; MUTAGENIC AGENT;

ANIMAL CELL; ARTICLE; BIG BLUE MOUSE; CARCINOGENICITY; CII GENE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DNA ISOLATION; ELECTRONIC CIGARETTE; FIBROBLAST; GENE FREQUENCY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INDUCED MUTATION; MOUSE; MUTAGENICITY; MUTATIONAL ANALYSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; REPORTER GENE; SUPF GENE; TRANSGENE; ULTRAVIOLET C RADIATION; VAPING; VAPOR; ANIMAL; DNA MUTATIONAL ANALYSIS; MUTAGENESIS; MUTATION RATE; SMOKING;

ANIMALS; DNA MUTATIONAL ANALYSIS; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FIBROBLASTS; HUMANS; MICE; MUTAGENESIS; MUTAGENS; MUTATION RATE; SMOKING;

EID: 85026921763     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2017.07.035     Document Type: Article

References (87)

1. Besaratinia, A., Tommasi, S., Electronic cigarettes: the road ahead. Prev. Med. 66 (2014), 65–67.
2. C.A. Schoenborn, R.M. Gindi, Electronic Cigarette Use Among Adults: United States, 2014, NCHS data brief, (2015) 1–8.
3. Singh, T., Arrazola, R.A., Corey, C.G., Husten, C.G., Neff, L.J., Homa, D.M., King, B.A., Tobacco use among middle and high school students—United States, 2011–2015: MMWR. Morbidity Mortality Wkly. Rep. 65 (2016), 361–367.
4. World Health Organization (WHO), Questions and Answers on Electronic Cigarettes or Electronic Nicotine Delivery Systems (ENDS). 2017, Tobacco Free Initiative (TFI) Statement2013.
5. World Health Organization (WHO), Electronic nicotine delivery systems Report by WHO., 2014, WHO Framework Convention on Tobacco Control, Geneva, Switzerland.
6. Wills, T.A., E-Cigarettes and adolescents' risk status. Pediatrics, 139, 2017.
7. Zhu, S.H., Sun, J.Y., Bonnevie, E., Cummins, S.E., Gamst, A., Yin, L., Lee, M., Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob. Control 23:Suppl. 3 (2014), iii3–iii9.
8. Farsalinos, K.E., Polosa, R., Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther. Adv. Drug Saf. 5 (2014), 67–86.
9. Farsalinos, K.E., Gillman, I.G., Melvin, M.S., Paolantonio, A.R., Gardow, W.J., Humphries, K.E., Brown, S.E., Poulas, K., Voudris, V., Nicotine levels and presence of selected tobacco-derived toxins in tobacco flavoured electronic cigarette refill liquids. Int. J. Environ. Res. Public Health 12 (2015), 3439–3452.
10. Oh, A.Y., Kacker, A., Do electronic cigarettes impart a lower potential disease burden than conventional tobacco cigarettes? Review on E-cigarette vapor versus tobacco smoke. Laryngoscope 124 (2014), 2702–2706.
11. Cheng, T., Chemical evaluation of electronic cigarettes. Tob. Control 23:Suppl. 2 (2014), ii11–ii17.
12. Sleiman, M., Logue, J.M., Montesinos, V.N., Russell, M.L., Litter, M.I., Gundel, L.A., Destaillats, H., Emissions from electronic cigarettes: key parameters affecting the release of harmful chemicals. Environ. Sci. Technol. 50 (2016), 9644–9651.
13. Han, S., Chen, H., Zhang, X., Liu, T., Fu, Y., Levels of selected groups of compounds in refill solutions for electronic cigarettes. Nicotine Tob. Res. 18 (2016), 708–714.
14. Department of Health, U.S., Human Services, US Food and Drug Administration, The Facts on the FDA's New Tobacco Rule. 2017, US Department of Health and Human Services, 2016.
15. Department of Health, U.S., Human Services, US Food and Drug Administration, Retailer Overview of FDA Regulations for Selling Tobacco Products. 2017, US Department of Health and Human Services, 2016.
16. Department of Health, U.S., Human Services, US Food and Drug Administration, FDA's New Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products. 2017, US Department of Health and Human Services, 2016.
17. Amrock, S.M., Zakhar, J., Zhou, S., Weitzman, M., Perception of e-cigarette harm and its correlation with use among U.S. adolescents. Nicotine Tob. Res. 17 (2015), 330–336.
18. Coleman, B.N., Johnson, S.E., Tessman, G.K., Tworek, C., Alexander, J., Dickinson, D.M., Rath, J., Green, K.M., It's not smoke. It's not tar. It's not 4000 chemicals. Case closed: exploring attitudes, beliefs, and perceived social norms of e-cigarette use among adult users. Drug Alcohol Depend. 159 (2016), 80–85.
19. Pepper, J.K., Byron, M.J., Ribisl, K.M., Brewer, N.T., How hearing about harmful chemicals affects smokers’ interest in dual use of cigarettes and e-cigarettes. Prev. Med. 96 (2017), 144–148.
20. Bernat, J.K., Ferrer, R.A., Margolis, K.A., Blake, K.D., US adult tobacco users’ absolute harm perceptions of traditional and alternative tobacco products, information-seeking behaviors, and (mis)beliefs about chemicals in tobacco products. Addict. Behav. 71 (2017), 38–45.
21. Kozlowski, L.T., Homish, D.L., Homish, G.G., Daily users compared to less frequent users find vape as or more satisfying and less dangerous than cigarettes, and are likelier to use non-cig-alike vaping products. Prev. Med. Rep. 6 (2017), 111–114.
22. Brown, J., Brown, B., Schwiebert, P., Ramakrisnan, K., McCarthy, L.H., In adult smokers unwilling or unable to quit, does changing from tobacco cigarettes to electronic cigarettes decrease the incidence of negative health effects associated with smoking tobacco? A clin-IQ. J. Patient Cent. Res. Rev. 1 (2014), 99–101.
23. Hajek, P., Etter, J.F., Benowitz, N., Eissenberg, T., McRobbie, H., Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 109 (2014), 1801–1810.
24. Pulvers, K., Emami, A.S., Nollen, N.L., Romero, D.R., Strong, D.R., Benowitz, N.L., Ahluwalia, J.S., Tobacco consumption and toxicant exposure of cigarette smokers using electronic cigarettes. Nicotine Tob. Res., 2016, 10.1093/ntr/ntw333 Dec 21. pii: ntw333. [Epub ahead of print].
25. Goniewicz, M.L., Gawron, M., Smith, D.M., Peng, M., Jacob, P. 3rd, Benowitz, N.L., Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-Subjects observational study. Nicotine Tob. Res. 19 (2017), 160–167.
26. Organisation for Economic Co-operation and Development (OECD), Guidance Document on Revisions to OECD Genetic Toxicology Test Guidelines, Genetic Toxicology Guidance Document: Second Commenting Round. Nov 30, 20152015.
27. Seidman, M.M., Dixon, K., Razzaque, A., Zagursky, R.J., Berman, M.L., A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells. Gene 38 (1985), 233–237.
28. Hauser, J., Seidman, M.M., Sidur, K., Dixon, K., Sequence specificity of point mutations induced during passage of a UV-irradiated shuttle vector plasmid in monkey cells. Mol. Cell. Biol. 6 (1986), 277–285.
29. Kelman, D.J., Christodoulou, D., Wink, D.A., Keefer, L.K., Srinivasan, A., Dipple, A., Relative mutagenicities of gaseous nitrogen oxides in the supF gene of pSP189. Carcinogenesis 18 (1997), 1045–1048.
30. Canella, K.A., Seidman, M.M., Mutation spectra in supF: approaches to elucidating sequence context effects. Mutat. Res. 450 (2000), 61–73.
31. Jakubczak, J.L., Merlino, G., French, J.E., Muller, W.J., Paul, B., Adhya, S., Garges, S., Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 9073–9078.
32. Lambert, I.B., Singer, T.M., Boucher, S.E., Douglas, G.R., Detailed review of transgenic rodent mutation assays. Mutat. Res. 590 (2005), 1–280.
33. Besaratinia, A., Pfeifer, G.P., Genotoxicity of acrylamide and glycidamide. J. Natl. Cancer Inst. 96 (2004), 1023–1029.
34. Kim, S.I., Pfeifer, G.P., Besaratinia, A., Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells. Cancer Res. 67 (2007), 11640–11647.
35. Besaratinia, A., Kim, S.I., Bates, S.E., Pfeifer, G.P., Riboflavin activated by ultraviolet A1 irradiation induces oxidative DNA damage-mediated mutations inhibited by vitamin C. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 5953–5958.
36. Besaratinia, A., Kim, S.I., Hainaut, P., Pfeifer, G.P., In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology 137 (2009), 1127–1137 1137 e1121-1125.
37. Besaratinia, A., Kim, S.I., Pfeifer, G.P., Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells. FASEB J. 22 (2008), 2379–2392.
38. Williams, M., Villarreal, A., Bozhilov, K., Lin, S., Talbot, P., Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One, 8, 2013, e57987.
39. Trtchounian, A., Williams, M., Talbot, P., Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob. Res. 12 (2010), 905–912.
40. Hua, M., Yip, H., Talbot, P., Mining data on usage of electronic nicotine delivery systems (ENDS) from YouTube videos. Tob. Control 22 (2013), 103–106.
41. Behar, R.Z., Luo, W., Lin, S.C., Wang, Y., Valle, J., Pankow, J.F., Talbot, P., Distribution, quantification and toxicity of cinnamaldehyde in electronic cigarette refill fluids and aerosols. Tob. Control 25 (2016), ii94–ii102.
42. Besaratinia, A., Bates, S.E., Pfeifer, G.P., Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer. Cancer Res. 62 (2002), 4331–4338.
43. Yoon, J.H., Besaratinia, A., Feng, Z., Tang, M.S., Amin, S., Luch, A., Pfeifer, G.P., DNA damage, repair, and mutation induction by (+)-Syn and (−)-anti-dibenzo[a l]pyrene-11,12-diol-13,14-epoxides in mouse cells. Cancer Res. 64 (2004), 7321–7328.
44. Besaratinia, A., Pfeifer, G.P., Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis. Carcinogenesis 27 (2006), 1526–1537.
45. Garganta, F., Krause, G., Scherer, G., Base-substitution profiles of externally activated polycyclic aromatic hydrocarbons and aromatic amines determined in a lacZ reversion assay. Environ. Mol. Mutagen. 33 (1999), 75–85.
46. Guo, X., Heflich, R.H., Dial, S.L., Richter, P.A., Moore, M.M., Mei, N., Quantitative analysis of the relative mutagenicity of five chemical constituents of tobacco smoke in the mouse lymphoma assay. Mutagenesis 31 (2016), 287–296.
47. Yoon, J.I., Kim, S.I., Tommasi, S., Besaratinia, A., Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice. Cancer Prev. Res. 5 (2012), 299–308.
48. Herskowitz, I., Hagen, D., The lysis-lysogeny decision of phage lambda: explicit programming and responsiveness. Annu. Rev. Genet. 14 (1980), 399–445.
49. Parris, C.N., Seidman, M.M., A signature element distinguishes sibling and independent mutations in a shuttle vector plasmid. Gene 117 (1992), 1–5.
50. Bacolla, A., Wang, G., Jain, A., Chuzhanova, N.A., Cer, R.Z., Collins, J.R., Cooper, D.N., Bohr, V.A., Vasquez, K.M., Non-B DNA-forming sequences and WRN deficiency independently increase the frequency of base substitution in human cells. J. Biol. Chem. 286 (2011), 10017–10026.
51. Levy, D.D., Groopman, J.D., Lim, S.E., Seidman, M.M., Kraemer, K.H., Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res. 52 (1992), 5668–5673.
52. Tommasi, S., Denissenko, M.F., Pfeifer, G.P., Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res. 57 (1997), 4727–4730.
53. Jacobsen, N.R., Saber, A.T., White, P., Moller, P., Pojana, G., Vogel, U., Loft, S., Gingerich, J., Soper, L., Douglas, G.R., Wallin, H., Increased mutant frequency by carbon black but not quartz, in the lacZ and cII transgenes of muta mouse lung epithelial cells. Environ. Mol. Mutagen. 48 (2007), 451–461.
54. Chen, G., Gingerich, J., Soper, L., Douglas, G.R., White, P.A., Induction of lacZ mutations in MutaMouse primary hepatocytes. Environ. Mol. Mutagen. 51 (2010), 330–337.
55. Besaratinia, A., Pfeifer, G.P., Enhancement of the mutagenicity of benzo(a)pyrene diol epoxide by a nonmutagenic dose of ultraviolet A radiation. Cancer Res. 63 (2003), 8708–8716.
56. Lemieux, C.L., Long, A.S., Lambert, I.B., Lundstedt, S., Tysklind, M., White, P.A., In vitro mammalian mutagenicity of complex polycyclic aromatic hydrocarbon mixtures in contaminated soils. Environ. Sci. Technol. 49 (2015), 1787–1796.
57. Matsuda, T., Kawanishi, M., Yagi, T., Matsui, S., Takebe, H., Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res. 26 (1998), 1769–1774.
58. Bigger, C.A., Strandberg, J., Yagi, H., Jerina, D.M., Dipple, A., Mutagenic specificity of a potent carcinogen benzo[c]phenanthrene (4R,3S)-dihydrodiol (2S,1R)-epoxide, which reacts with adenine and guanine in DNA. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), 2291–2295.
59. Ross, H.L., Lee, H., Harvey, R.G., Dipple, A., Comparison of the sites of reaction of three polycyclic aromatic hydrocarbons in the supF gene. Mutat. Res. 306 (1994), 91–101.
60. Bigger, C.A., Ponten, I., Page, J.E., Dipple, A., Mutational spectra for polycyclic aromatic hydrocarbons in the supF target gene. Mutat. Res. 450 (2000), 75–93.
61. Routledge, M.N., McLuckie, K.I., Jones, G.D., Farmer, P.B., Martin, E.A., Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV-induced DNA single strand breaks and supF gene mutations. Carcinogenesis 22 (2001), 1231–1238.
62. Tompkins, E.M., McLuckie, K.I., Jones, D.J., Farmer, P.B., Brown, K., Mutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cells. Mutat Res. 678 (2009), 129–137.
63. Kleykamp, B.A., Jennings, J.M., Sams, C., Weaver, M.F., Eissenberg, T., The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Exp. Clin. Psychopharmacol. 16 (2008), 99–112.
64. Dawkins, L., Corcoran, O., Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology 231 (2014), 401–407.
65. Thorne, D., Crooks, I., Hollings, M., Seymour, A., Meredith, C., Gaca, M., The mutagenic assessment of an electronic-cigarette and reference cigarette smoke using the Ames assay in strains TA98 and TA100. Mutat. Res. 812 (2016), 29–38.
66. Misra, M., Leverette, R.D., Cooper, B.T., Bennett, M.B., Brown, S.E., Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int. J. Environ. Res. Public Health 11 (2014), 11325–11347.
67. Goniewicz, M.L., Knysak, J., Gawron, M., Kosmider, L., Sobczak, A., Kurek, J., Prokopowicz, A., Jablonska-Czapla, M., Rosik-Dulewska, C., Havel, C., Jacob, P. 3rd, Benowitz, N., Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 23 (2014), 133–139.
68. Hutzler, C., Paschke, M., Kruschinski, S., Henkler, F., Hahn, J., Luch, A., Chemical hazards present in liquids and vapors of electronic cigarettes. Arch. Toxicol. 88 (2014), 1295–1308.
69. Jensen, R.P., Luo, W., Pankow, J.F., Strongin, R.M., Peyton, D.H., Hidden formaldehyde in e-cigarette aerosols. N. Engl. J. Med. 372 (2015), 392–394.
70. Kosmider, L., Sobczak, A., Fik, M., Knysak, J., Zaciera, M., Kurek, J., Goniewicz, M.L., Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob. Res. 16 (2014), 1319–1326.
71. Talih, S., Balhas, Z., Salman, R., Karaoghlanian, N., Shihadeh, A., Direct dripping: a high-temperature, high-formaldehyde emission electronic cigarette use method. Nicotine Tob. Res. 18 (2016), 453–459.
72. Hecht, S.S., Carmella, S.G., Kotandeniya, D., Pillsbury, M.E., Chen, M., Ransom, B.W., Vogel, R.I., Thompson, E., Murphy, S.E., Hatsukami, D.K., Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob. Res. 17 (2015), 704–709.
73. Shahab, L., Goniewicz, M.L., Blount, B.C., Brown, J., McNeill, A., Alwis, K.U., Feng, J., Wang, L., West, R., Nicotine, carcinogen, and toxin exposure in long-term E-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann. Intern. Med. 166 (2017), 390–400.
74. Bekki, K., Uchiyama, S., Ohta, K., Inaba, Y., Nakagome, H., Kunugita, N., Carbonyl compounds generated from electronic cigarettes. Int. J. Environ. Res. Public Health 11 (2014), 11192–11200.
75. Walton, K., NIDA Development of a Standardized E-Cigarette to Support Clinical Research. 2017, National Institute on Drug Abuse http://www.e-cigarette-summit.us.com/files/2017/05/Kevin-Walton.pdf.
76. Yoon, J.H., Smith, L.E., Feng, Z., Tang, M., Lee, C.S., Pfeifer, G.P., Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res. 61 (2001), 7110–7117.
77. Luch, A., Nature and nurture—lessons from chemical carcinogenesis, Nature reviews. Cancer 5 (2005), 113–125.
78. Tsai, H.C., Baylin, S.B., Cancer epigenetics: linking basic biology to clinical medicine. Cell Res. 21 (2011), 502–517.
79. Rodriguez-Paredes, M., Esteller, M., Cancer epigenetics reaches mainstream oncology. Nat. Med. 17 (2011), 330–339.
80. Baylin, S.B., Jones, P.A., A decade of exploring the cancer epigenome − biological and translational implications, Nature reviews. Cancer 11 (2011), 726–734.
81. Sandoval, J., Esteller, M., Cancer epigenomics: beyond genomics. Curr. Opin. Genet. Dev. 22 (2012), 50–55.
82. Dawson, M.A., Kouzarides, T., Cancer epigenetics: from mechanism to therapy. Cell 150 (2012), 12–27.
83. Stirzaker, C., Taberlay, P.C., Statham, A.L., Clark, S.J., Mining cancer methylomes: prospects and challenges. Trends Genet. 30 (2014), 75–84.
84. Henikoff, S., Smith, M.M., Histone variants and epigenetics. Cold Spring Harbor Perspect. Biol., 7, 2015, a019364.
85. Jones, P.A., Issa, J.P., Baylin, S., Targeting the cancer epigenome for therapy. Nat. Rev. Genet. 17 (2016), 630–641.
86. Flavahan, W.A., Gaskell, E., Bernstein, B.E., Epigenetic plasticity and the hallmarks of cancer. Science, 357, 2017.
87. Benowitz, N.L., Fraiman, J.B., Cardiovascular effects of electronic cigarettes. Nat. Rev. Cardiol. 14 (2017), 447–456.